These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 23154867

  • 21. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A.
    J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370
    [Abstract] [Full Text] [Related]

  • 22. [A case of atypical hemolytic uremic syndrome successfully weaned from plasma exchange by treatment with eculizumab].
    Nagata A, Ohara A, Wakasugi D, Natori C, Ito S, Taguchi K, Fukami K, Okuda S.
    Nihon Jinzo Gakkai Shi; 2014 Apr 29; 56(5):606-11. PubMed ID: 25130033
    [Abstract] [Full Text] [Related]

  • 23. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F.
    Pediatr Nephrol; 2013 Jan 29; 28(1):155-8. PubMed ID: 22956028
    [Abstract] [Full Text] [Related]

  • 24. Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?
    Saland J.
    Pediatr Nephrol; 2014 Mar 29; 29(3):329-32. PubMed ID: 24362724
    [Abstract] [Full Text] [Related]

  • 25. Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.
    Sinibaldi S, Guzzo I, Piras R, Bresin E, Emma F, Dello Strologo L.
    Pediatr Transplant; 2013 Dec 29; 17(8):E177-81. PubMed ID: 24118826
    [Abstract] [Full Text] [Related]

  • 26. Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy.
    Zlamy M, Hofer J, Elias J, Vogel U, Frosch M, Jungraithmayr T, Zimmerhackl LB, Prelog M.
    Pediatr Transplant; 2012 Sep 29; 16(6):E246-50. PubMed ID: 21967634
    [Abstract] [Full Text] [Related]

  • 27. Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.
    Tschumi S, Gugger M, Bucher BS, Riedl M, Simonetti GD.
    Pediatr Nephrol; 2011 Nov 29; 26(11):2085-8. PubMed ID: 21877169
    [Abstract] [Full Text] [Related]

  • 28. Eculizumab for atypical hemolytic-uremic syndrome.
    Nürnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, Kribben A, Zimmerhackl LB, Janecke AR, Nagel M, Kirschfink M.
    N Engl J Med; 2009 Jan 29; 360(5):542-4. PubMed ID: 19179328
    [No Abstract] [Full Text] [Related]

  • 29. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N.
    Intern Med J; 2015 Oct 29; 45(10):1054-65. PubMed ID: 26247170
    [Abstract] [Full Text] [Related]

  • 30. Anti-C5 as prophylactic therapy in atypical hemolytic uremic syndrome in living-related kidney transplantation.
    Pelicano MB, de Córdoba SR, Diekmann F, Saiz M, Herrero S, Oppenheimer F, Campistol JM.
    Transplantation; 2013 Aug 27; 96(4):e26-9. PubMed ID: 23958887
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E, Alberti M, Noris M.
    J Nephrol; 2012 Aug 27; 25(6):911-7. PubMed ID: 22760880
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An unusual case of haemolytic uraemic syndrome following endoscopic retrograde cholangiopancreatography rapidly improved with eculizumab.
    Taton O, Delhaye M, Stordeur P, Goodship T, Le Moine A, Massart A.
    Acta Gastroenterol Belg; 2016 Aug 27; 79(2):257-61. PubMed ID: 27382949
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.